Build trust with society

Our long-term success depends on building and maintaining trust with society. We strive to meet the expectations of our stakeholders by making our medicines available to as many people as possible, by acting ethically, and by making a positive difference for society while minimizing our environmental impact.

2021 highlights

56.2 m

Patients reached
through access approaches

1 bn

Antimalarial treatments
delivered to patients since 1999, with more than 90% supplied without profit

31%

Increase in patients reached
through emerging market brands

-34%

Greenhouse gas emissions
reduced vs. 2016 baseline (Scope 1 and Scope 2)

In this section

Leading the way on access and global health Improving access to medicines remains one of the world’s greatest healthcare needs. We seek to expand access to underserved patient populations while addressing major global health challenges.

Access principle 1: research and development

Access principle 2: affordability

Access principle 3: strengthening healthcare systems

Expanding access through generics and biosimilars

Holding ourselves to high ethical standards Our stakeholders expect us to act with high ethical standards wherever we operate. We are making progress in embedding ethics and human rights across our company.

Upholding our commitment to human rights

Encouraging employees to speak up

Commitment to transparency and disclosure

Being a responsible citizen Novartis is committed to playing a positive and constructive role in society by addressing issues such as environmental sustainability and antimicrobial resistance.

Enhancing environmental sustainability

Advancing our program to combat antimicrobial resistance

Conducting animal research responsibly

Related links and disclosures:

Position on Access to Medicines

Position on Value-Based Healthcare

Anti-Bribery Report

Environmental Sustainability Strategy

Human Rights Commitment Statement